Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.

Du, Xuemei; Gao, Ying; Zhao, Hongyu; Li, Bin; Xue, Weimin; Wang, Daye

Du, Xuemei; Gao, Ying; Zhao, Hongyu; Li, Bin; Xue, Weimin; Wang, Daye.

Afiliación

Du X; Department of Pathology, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing 100038, P.R. China.
Gao Y; Department of Pathology, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing 100038, P.R. China.
Zhao H; Department of Pathology, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing 100038, P.R. China.
Li B; Department of Nuclear Magnetic Resonance, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing 100038, P.R. China.
Xue W; Cyttel Biosciences Inc., Beijing 101111, P.R. China.
Wang D; Department of Pathology, Basic Medical College, Capital Medical University, Beijing 100069, P.R. China.

Oncol Lett ; 15(6): 9317-9326, 2018 Jun.

Article en En | MEDLINE | ID: mdl-29805657

Palabras clave

epithelioid inflammatory myofibroblastic sarcoma; immunohistochemistry; programmed cell-death ligand 1; therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncol Lett Año: 2018 Tipo del documento: Article Pais de publicación: Grecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google